Patent · US Active

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

US10329538B2 · kind B2 · utility

3Cited by

3References

23Claims

0Family size

Assignee

University of Georgia Research Foundation, Inc. · US

Inventors

Brian Jordan · Watkinsville, US
Mark W. Jackwood · Watkinsville, US

Key dates

Filing date	Jan 26, 2018
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Jan 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/20071
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Attenuated isolates of the Arkansas serotype of infectious bronchitis virus (IBV), including the IBV isolate ArkGA p60 deposited at the ATCC under Patent Designation PTA-123783, and compositions thereof are presented. Methods for administering the isolates or compositions as vaccines to the prevent virulent IBV infection in birds of the order Galliformes are also presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.